Filed before 2025Filed 31 January 2017
PhaseBio Pharmaceuticals Inc raised $6.62M
PhaseBio Pharmaceuticals Inc, a biotech company based in Malvern, PA, raised $6.62M in a new convertible round, according to a filing dated 31 January 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 31 January 2017
- Round
- Convertible round
- Amount sold
- $6.62M
- Offering size
- $7.88M
- Investors so far
- 9
- Based in
- Malvern, PA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 55% of the 1,645 tracked raises with an amount filed in 2017, and than 36% of the 152 in biotech.
PhaseBio Pharmaceuticals Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 10 Sep 2018 | New filing | $26M | Another raise |
| 31 Jan 2017 | New filing | $6.62M | This raise |
| 21 Jul 2015 | Amended filing | $21M | Another raise |
| 12 Mar 2015 | New filing | $20M | Another raise |
More with Hatteras on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.